{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-049645","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.118464+00:00","generated_at":"2026-05-29T04:38:10.645303+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NanoVibronix renews PainShield distribution deal with Ultra Pain; secures $12M minimum purchase commitment","bullets":["Renewed exclusive distribution agreement with Ultra Pain Products for PainShield for five years.","Minimum purchase commitment valued at $12 million over the term of the agreement.","CEO Brian Murphy highlighted UPPI's growth and transition into manufacturing as key factors.","PainShield is a non-opioid portable ultrasound device for pain management and injury recovery."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-049645","json":"https://secwatch.observer/filing/0001493152-24-049645.json","markdown":"https://secwatch.observer/filing/0001493152-24-049645.md","text":"https://secwatch.observer/filing/0001493152-24-049645.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224049645/0001493152-24-049645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224049645/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:38:10.645303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}